Drug Resistance Mechanisms on Colorectal Cancer
نویسندگان
چکیده
Standard treatment for colorectal cancer includes surgery, radiotherapy, and chemotherapy. Conventional chemotherapeutic agents used in such as 5-fluorouracil, capecitabine which is oral form of irinotecan, oxaliplatin. One the major challenges chemotherapy considered drug resistance. Drug resistance occurs many different mechanisms alteration tumor microenvironment, growth kinetics, genetic variations, heterogeneity. These cytotoxic are combination to overcome on cancer. They can also be with bevacizumab cetuximab. Combination therapy depends burden, type, stage, molecular characteristics. It crucial choose applied by taking these factors into consideration. In this review, current were discussed then conventional related explained.
منابع مشابه
Mechanisms of cancer drug resistance.
The design of cancer chemotherapy has become increasingly sophisticated, yet there is no cancer treatment that is 100% effective against disseminated cancer. Resistance to treatment with anticancer drugs results from a variety of factors including individual variations in patients and somatic cell genetic differences in tumors, even those from the same tissue of origin. Frequently resistance is...
متن کاملHybrid Modeling of Cancer Drug Resistance Mechanisms
Cancer is a multi-scale disease and its overwhelming complexity depends upon the multiple interwind events occurring at both molecular and cellular levels, making it very difficult for therapeutic advancements in cancer research. The resistance to cancer drugs is a significant challenge faced by scientists nowadays. The roots of the problem reside not only at the molecular level due to multiple...
متن کاملMechanisms of drug resistance in cancer chemotherapy.
The management of cancer involves procedures, which include surgery, radiotherapy and chemotherapy. Development of chemoresistance is a persistent problem during the treatment of local and disseminated disease. A plethora of cytotoxic drugs that selectively, but not exclusively, target actively proliferating cells include such diverse groups as DNA alkylating agents, antimetabolites, intercalat...
متن کاملMechanisms of resistance to anti-EGFR therapy in colorectal cancer
Targeting the epidermal growth factor receptor (EGFR) either alone or in combination with chemotherapy is effective for patients with RAS wild type metastatic colorectal cancer (mCRC). However, only a small percentage of mCRC patients are sensitive to anti-EGFR therapy and even the best cases finally become refractory to this therapy. It has become apparent that the RAS mutations correlate with...
متن کاملBufalin reverses ABCB1-mediated drug resistance in colorectal cancer
Multidrug resistance (MDR), mainly mediated by ABCB1 transporter, is a major cause for chemotherapy failure. Bufalin (BU), an active component of the traditional Chinese medicine chan'su, has been reported to have antitumor effects on various types of cancer cells. The purpose of this present study was to investigate the reversal effect of BU on ABCB1-mediated multidrug resistance in colorectal...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of basic and clinical health sciences
سال: 2021
ISSN: ['2458-8938', '2564-7288']
DOI: https://doi.org/10.30621/jbachs.869310